Dauch Corp Reports Strong Q1 Post-Acquisition, Raises Full-Year Sales and EBITDA Guidance
summarizeSummary
Dauch Corp reported Q1 2026 results with significant sales growth from the Dowlais acquisition, a GAAP net loss, but positive adjusted EPS and a slight raise in full-year guidance for sales and Adjusted EBITDA.
check_boxKey Events
-
Q1 2026 Financial Results
Reported sales of $2.38 billion, a net loss attributable to Dauch of $(100.3) million, diluted loss per share of $(0.52), but adjusted earnings per share of $0.34 and Adjusted EBITDA of $308.5 million.
-
Updated Full-Year 2026 Guidance
Raised the upper end of full-year sales guidance to $10.3 - $10.8 billion (from $10.3 - $10.7 billion) and Adjusted EBITDA guidance to $1.3 - $1.425 billion (from $1.3 - $1.4 billion).
-
Impact of Dowlais Acquisition
The transformational acquisition of Dowlais Group plc was the primary driver of year-over-year changes in financial results, contributing to significant sales growth and integration synergies.
-
Cash Flow Performance
Reported net cash used in operating activities of $(64.4) million and adjusted free cash flow use of $(40.8) million for the quarter.
auto_awesomeAnalysis
Dauch Corporation reported its first-quarter 2026 financial results, showcasing significant sales growth primarily driven by the recent Dowlais acquisition. While the company recorded a GAAP net loss of $(100.3) million, adjusted earnings per share were positive at $0.34, an improvement from the prior year. Management expressed confidence in the integration of Dowlais, citing a strong start and progress in capturing synergies. Crucially, the company slightly raised its full-year 2026 guidance for both sales and Adjusted EBITDA, signaling an improving outlook despite continued cash usage from operations and free cash flow. This update provides a more optimistic trajectory following the transformational acquisition.
At the time of this filing, DCH was trading at $5.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $3.94 to $9.25. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.